Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
about
Multiple sclerosis--new treatment modalitiesThe real-world effectiveness and safety of fingolimod in relapsing-remitting multiple sclerosis patients: An observational study.Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French CenterFingolimod-associated PML in a patient with prior immunosuppression.Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East.Sphingosine 1-Phosphate Receptor Modulator Fingolimod (FTY720) Attenuates Myocardial Fibrosis in Post-heterotopic Heart Transplantation.
P2860
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fingolimod Treatment in Relaps ...... lticenter Postmarketing Study.
@ast
Fingolimod Treatment in Relaps ...... lticenter Postmarketing Study.
@en
type
label
Fingolimod Treatment in Relaps ...... lticenter Postmarketing Study.
@ast
Fingolimod Treatment in Relaps ...... lticenter Postmarketing Study.
@en
prefLabel
Fingolimod Treatment in Relaps ...... lticenter Postmarketing Study.
@ast
Fingolimod Treatment in Relaps ...... lticenter Postmarketing Study.
@en
P2093
P2860
P356
P1476
Fingolimod Treatment in Relaps ...... lticenter Postmarketing Study.
@en
P2093
Antonio Carolei
Aurora Fuiani
Carmine Marini
Caterina Di Carmine
Ciro Mundi
Gianfranco Costantino
Paolo Bellantonio
Roberta Fantozzi
Rocco Totaro
Stefano Ruggieri
P2860
P304
P356
10.1155/2015/763418
P577
2015-07-22T00:00:00Z